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Hemorrhage is a devastating event that can occur in the perioperative period. It is estimated that
2.35 in 1000 patients will experience hemorrhage associate with surgery.1Adverse outcomes
affecting patient morbidity, mortality and quality of life are associated with hemorrhage.2 Timely
detection, diagnosis and appropriate intervention in the setting of hemorrhage are imperative to
reduce adverse outcomes of shock such as end organ damage, chronic disability or death.
Anesthesia practitioners hold the charge of monitoring and managing the patient’s hemodynamic
status and play an integral role in the detection and management of the hemorrhaging patient.
Case Report
A 71 year old male with hypertension, COPD and kidney disease presented with a large renal
mass for laparoscopic/possible open nephrectomy. Medications included lisinopril, rouvastatin,
aspirin. Preoperative labs revealed hemoglobin 14 gm/dL, hematocrit 41% creatinine 0.89
mg/dL. 2 mg versed given and patient was brought to the OR. Blood pressure, ECG and Sp02
monitors applied. Placement of epidural (ED) catheter and arterial line performed. ED catheter
dosed with 5 ml 0.25% ropivicaine 50 mcg fentanyl. Phenylephrine drip was initiated 10
mcg/kg/min stabilizing arterial blood pressure (ABP). Induction of anesthesia proceeded with 50
mcg fentanyl 160 mg propofol 8 mg vecuronium. Direct laryngoscopy performed and trachea
intubated. Respirations controlled with mechanical ventilation and warmed IV fluid and
convection heating initiated. Anesthesia was maintained with 3% inspired concentration in a
mixture of 1L/min oxygen and 1L/min air. Phenylephrine drip was titrated to achieve mean
arterial pressure of 70 mm/Hg. Fluid intake, blood loss and urine output (UO) closely monitored.
Conversion to open procedure was necessary due to bleeding obscuring the surgical field. 600 ml
blood loss was appreciated and crystalloid bolus delivered. Removal of kidney was achieved.
Neuromuscular blockade antagonized and 5 ml 0.25% ropivicaine 50 mcg fentanyl via ED
catheter was delivered. During emergence from anesthesia ABP decreased to 77/50 mmHg;
phenylephrine increased to 40 mcg/min achieving adequate ABP. Awake extubation performed
without incident. Shortly after arrival to PACU level of consciousness (LOC) and ABP
decreased. A crystalloid bolus was delivered and phenylephrine drip increased. H&H drawn;
resulted 7.5/25%. Two units PRBC’s delivered; H&H post-transfusion 7.1/23%. Surgeon and
anesthesia team consulted about patient status. Assessment of drain output, inspection of
abdomen, back and incision performed with nothing abnormal noted. Patient was obtunded with
periods of intermittent arousal. Two units FFP and two units PRBC’s delivered. 20 U
vasopressin titrated intravenously to support ABP. Crystalloid resuscitation continued and 25
gm albumin delivered. Oliguria, diaphoresis, persistent hypotension and mild tachycardia noted

with waxy skin tone. Phenylephrine increased 250 mcg/min and epinephrine drip initiated with
no significant improvement. Calcium gluconate administered. ABG was drawn and resulted- pH
7.1 and a base excess of -23. Emergent intubation of trachea and initiation of mechanical
ventilation performed. Return to the operating room for exploration revealed a liver laceration
and 2.5 liters of blood was evacuated from the abdomen. In total 10 units PRBC’s and 6 units
FFP were infused. Patient admitted to ICU intubated and unconscious on vasopressor support
with phenylephrine and epinephrine. Postoperative ABG revealed severe metabolic acidosis.
Post-operative day one patient was unresponsive, anuric, creatinine 2.3mg/dL and in liver shock
requiring evacuation by helicopter for tertiary care. Patient returned to the VA hospital a week
later, alert and oriented and was admitted to medical floor. At tertiary facility hemodialysis was
performed for acute renal failure. The patient’s creatinine levels remained > 5.0 mg/dL and
hemodialysis continuation was necessary. Liver enzymes returned to normal and plan for
inpatient rehabilitation was planned due to extreme physical deconditioning.
Discussion
This case demonstrates the importance of timely and efficient intervention in the setting of
ensuing symptoms of shock in the postoperative setting. The cardinal findings seen in the shock
continuum include hypotension, oliguria, altered mental status, metabolic acidosis, and cool
clammy skin.3 When hemorrhage is not overt the anesthesia practitioner must have a
comprehensive knowledge base in order to detect and treat shock when symptoms arise in order
to avoid deleterious consequences.
Many factors can contribute to postoperative hypotension. If bleeding is occult then judicious
review of potential contributors needs to be explored. In this case, total estimated blood loss was
approximately 750 ml; an allowable blood loss of 1500 ml was calculated preoperatively. The
patient received 5300 ml of crystalloid fluid intra-operatively and urine output was calculated at
470 ml. Post-operative fluid deficit was not determined an obvious cause of hypotension and
shock symptoms. Neuraxial anesthesia and repeat epidural dosing of local anesthetic and opioid
at the end of the case was considered to be of etiological significance as a potential cause for
hypotension and resultant hypoxemia. Timing, dosing and duration of action of the local
anesthetic was reviewed and the patient’s motor function was assessed. It was determined that
the epidural was not likely to be a causative factor of the hemodynamic instability.
Treatment of shock should never be delayed during once it is suspected and possible hemorrhage
should be considered. Crystalloid resuscitation due to its ability to rapidly expand plasma volume
and reverse hypotension continues to be the first line treatment for shock and with suspected
hemorrhage.4 The patient was bolused two liters of crystalloid followed by continuous delivery
of lactated Ringer’s solution. Current studies suggest that there is no clear advantage to use of
colloid based fluids compared to crystalloid solution during fluid resuscitation in the setting of
shock, although some findings reveal an advantage when colloids are delivered concurrently.5,6
Albumin was delivered in this case to procure the possible advantage associated with addition of
intravascular colloids.
Vasopressors are recommended in the treatment of shock if initial fluid bolus does not correct
hemodynamics.7 Phenylephrine was delivered throughout the resuscitation process and

vasopressin and epinephrine were added when limited response was noted with phenylephrine
alone.
Concurrent with fluid resuscitation, assessment of pertinent lab values should be performed.
Hemoglobin and hematocrit (H&H) levels were drawn and revealed decreased values suggestive
of acute blood loss when compared to preoperative labs. Blood transfusion was initiated and
repeating the H&H helped guide the need for subsequent blood transfusions.
Unfortunately, a serum lactate was never obtained and could have offered information early on
in the process. The ability to clear lactate and normalize lactate levels is reflective of the severity
of the shock state; if lactate clearance does not normalize post resuscitation this should instigate
suspicion of occult bleeding.8 Arterial blood gas analysis (ABG) was performed but it was drawn
well after symptoms were apparent and when the patient status was declining. Earlier obtainment
and trending of ABG’s could have instigated earlier intubation and treatment the developing
metabolic acidosis. No coagulation studies were obtained.
Maintenance of body temperature above 35°C decreases the affinity for oxygen to bind to
hemoglobin and tissue oxygenation.8 Hypothermia instigates coagulopathies and alterations in
glucose handling thereby increasing bleeding and altering metabolic processes.8 Although the
blood products were warmed upon delivery, convection warming and warming of IV fluids was
not performed. Also, temperature monitoring was sporadic and patient was found to be
hypothermic upon intermittent assessment.
In retrospection, there was immediate awareness of a shock state occurring in the patient and
many imperative interventions were initiated in a timely manner. Key components such as
immediate fluid resuscitation and stepwise vasopressor initiation were performed. Critique of
the process would include failure to obtain important lab values such as serum lactate,
coagulation panel and early obtainment of an ABG analysis that may have resulted in decreased
metabolic derangement, decreased end organ failure and earlier intubation. The patient suffered
severe hypo-perfusion of the liver and kidney during the resuscitative process resulting in
persistent renal failure and the need for ongoing hemodialysis. More aggressive warming
measures should have been applied to maintain an adequate internal body temperature and
support improved tissue perfusion.
Ultimately, accurate discernment that a hemorrhage was the cause of shock and return to
operating room for exploration and repair of the laceration of the liver allowed for the survival of
the patient. In the future, an algorithm of care in the form of a cognitive visual aid that helps to
guide practitioners in the delivery of all key components of shock resuscitation while discerning
the etiology of postoperative shock would help to minimize unfavorable consequences.
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Abstract
Shock is an adverse physiological occurrence that is life threatening and is associated with high
morbidity and mortality for those affected. In the perioperative period many factors are present
that challenge the maintenance of homeostasis and can facilitate a shock state in the patient.
Anesthesia providers are responsible for assessing, monitoring and maintaining cardiovascular
and physiologic stability. High risk surgeries with potential for increased blood loss, long

duration operations, fluid losses and the types of procedures, the patients age and current state of
health are just a few variables that place the patient at risk of shock. At the head of the bed the
anesthetist is the sole provider who holds the primary role in detection, intervention, and
treatment of shock as it ensues. Knowledge of the types and stages of shock and an awareness of
current best practices regarding how to detect, support and treat shock will provide the best
outcomes for the patient.
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Identification, Treatment and Management of Shock in the Surgical Patient
Shock
Shock is defined as a state of significantly reduced systemic tissue perfusion causing

decreased oxygen delivery to body tissues leading to an imbalance between oxygen delivery and
oxygen consumption (Gaieski, 2015). Predicting that shock may be ensuing and having it high
on a diagnostic differential for the patient is imperative due to the deleterious sequelae of events
and adverse outcomes associated with hypoperfusion that occurs in the shock state. Prolonged
states of oxygen deprivation results in derangement of cellular function manifesting as cell
membrane ion pump dysfunction, intracellular edema, leaking of intracellular contents and
alterations in ability to regulate intracellular pH. Without intervention systemic effects ensue
characterized by alterations of serum pH, endothelial dysfunction and stimulation of
inflammatory processes in the body. Shock states are initially reversible but if left untreated can
develop into an irreversible process involving cell death, end organ damage, multi organ system
failure and death (Gaieski, 2015).
Categories of Shock
Shock is categorized into three primary types: hypovolemic, cardiogenic and distributive.
Each type can be differentiated by cardiac output and by systemic vascular resistance states.
More than one type of shock can be experienced at one time, for instance, cardiogenic shock can
develop concurrently with hypovolemic shock.
Hypovolemic shock occurs as a result of decreased cardiac preload due to intravascular
volume loss and is primarily induced by either acute or occult blood loss or inadequate fluid
replacement peri-operatively. Cardiac output decreases along with the decreased preload and
systemic vascular resistance increases in a compensatory effort to continue adequate perfusion to
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vital organs (Dutton, 2007). In hemorrhagic shock, stasis of bleeding is the most important and
definitive treatment.
Cardiogenic shock is a consequence of cardiac pump failure, which decreases cardiac
output (CO). Systemic vascular resistance then increases in an effort to compensate for the
diminished CO to maintain perfusion. Common categories of cardiogenic shock etiology

include myopathic, arrhythmic, mechanical, or extracardiac, sometimes called obstructive shock.
Moypathic cardiogenic shock can be caused by myocardial infarction (especially when greater
than 40% of the ventricular wall is involved), dilated cardiomyopathies, stunned myocardium
following prolonged ischemia and myocarditis (Gaieski, 2015). Arrhythmic born cardiogenic
shock can be induced by both atrial and ventricular arrhythmias (Gaieski, 2015). Mechanical
causes of cardiogenic shock include valvular and septal defects or ruptures, ruptured ventricular
wall aneurysms, critical aortic stenosis or dissection of ascending aortic aneurysm (Gaieski,
2015). Etiological examples of obstructive shock include massive pulmonary emboli, cardiac
tamponade, tension pneumothorax and severe constrictive pericarditis (Gaieski, 2015).
Conversely, distributive or vasodilatory shock is a consequence of severely decreased
systemic vascular resistance and cardiac output is typically increased in an effort to compensate
for the diminished systemic vascular resistance. Some causes of distributive shock are sepsis,
systemic inflammatory response syndrome seen with pancreatitis, burns and multiple trauma
situations, anaphylaxis, neurogenic shock, myxedema coma, and post myocardial infarction
inflammation (Gaieski, 2015).
Stages of Shock
Anesthesia providers must have a strong understanding of the shock continuum in
order to detect, diagnose, support and treat the patient effectively. There are multiple staging
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frameworks for shock identifying anywhere from three to six stages in the continuum.
Comprehensively there are four primary stages of shock: initial, compensatory, progressive and
refractory (Tintinalli, 2010). The stages are differentiated by the severity of circulatory
compromise and they are progressive, complex and can overlap (Gaieski, 2015).
The initial stage is associated with up to 15% blood volume loss; approximately 750 ml.
In this stage hypoperfusion causes tissue hypoxia and creates excess lactate due to a lack of
oxygen to act as an electron acceptor in the electron transport chain and consequently slowing
down the speed at which pyruvate enters into the Kreb’s cycle. Serum lactate begins to rise in
this early stage of shock and constriction of the vascular bed begins. Mental status, blood
pressure and respiratory rate remain normal (Tintinalli, 2010).
Stage two, the compensatory stage of shock (also known as warm shock) is associated
with a 15-30% blood volume loss; approximately 750-1000ml (Tintinalli, 2010). Stage two
begins with compensation for decreased tissue perfusion by activating innate physiologic
mechanisms such as stimulation of arterial baroreceptors, changes in respiratory rate responding
to an increasing blood pH, outflow of endogenous catecholamines causing vasoconstriction, and
stimulation of the renin-angiotensin system by increased secretion of antiduretic hormone from
the pituitary gland (Tintinalli, 2010). Activation of these mechanisms has the common goal of
delivering oxygen to vital organs such as the heart lung and brain. Physical signs of
compensatory shock include tachypnea, tachycardia, narrowing pulse pressure, normal systolic
blood pressure, increased diastolic blood pressure, possible reduced urine output, peripheral
vasoconstriction and mild restlessness (Tintinalli, 2010). These compensatory mechanisms can
allow for an up to ten percent decrease in circulating arterial blood volume without overt
symptoms making compensated shock difficult to detect (Gaieski, 2015).
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The third stage, progressive shock, is associated with a 30-40% blood volume loss,
approximately1500-2000ml (Tintinalli, 2010) and a decrease in cardiac index to less than
2.5L/min/m2 (Gaieski, 2015). In this stage compensation begins to fail; sustained hypoperfusion
leads to inappropriate cellular handling of sodium and potassium, electrolyte disturbances,
worsening metabolic acidosis, increased hydrostatic pressure in the capillaries leading to fluid
and protein leaking into the interstitium, histamine release and under-perfused vital organs
(Tintinalli, 2010). Signs and symptoms present as a drop in systolic blood pressure to 100
mmHg or less, tachycardia, tachypnea, diaphoresis, confusion, oliguria, metabolic acidosis cool
clammy skin to touch.
If left untreated the patient will progress to the fourth stage, refractory shock, which is
associated with blood loss of 40% or more; approximately 2000ml (Tintinalli, 2010). This is a
dire stage where end organ dysfunction and failure occurs and is often irreversible leading to cell
death, brain damage and mortality. In this stage adenosine triphosphate (ATP), our metabolic
cellular currency degrades to adenosine in the absence of available oxygen. Adenosine leaks into
the extracellular fluid, further contributing to capillary vasodilation, and finally transforms into
uric acid worsening an acidemic state. As adenosine is depleted restoration of oxygenation is
futile in the absence of adenosine as a substrate to form ATP (Tintinalli, 2010). Hallmarks of
this stage include extreme tachycardia, weak pulses, decrease in systolic blood pressure (70
mmHg or less) anuria and renal failure, restlessness, obtundation and coma (Tintinalli, 2010,
Gaieski, 2015). Survival at this stage is very unlikely.
Monitoring: Basic and Invasive
Basic noninvasive monitoring of blood pressure, oxygen saturation, heart rate and rhythm
along with constant physical assessment is immediately required for the patient in shock.
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Invasive monitoring is imperative if the shock continuum progresses. Placement of an arterial
line is essential to accurately and continuously monitor arterial blood pressure while offering
information about valvular and ventricular function as well as serving as a portal for arterial
blood sampling. A central venous catheter can be placed to monitor central venous pressure and
help guide fluid resuscitation needs along with providing multiple ports for fluid and vasopressor
administration. Pulmonary artery catheters are less frequently utilized today but placement can
provide cardiac output and cardiac index measurements assisting with decision making in regard
to pharmacological support. A urinary catheter allows for monitoring of urine output and can
assist in identifying progression of end organ failure in the shock patient.
Further diagnostic tests that are useful in the identification and classification of shock are
chest radiology, electrocardiogram, and echocardiogram. Results of these tests can help to rule
in or rule out different types of shock depending on the findings. For instance, acute pulmonary
edema upon chest x-ray and evidence of myocardial infarction on ECG can predict that the
patient is experiencing cardiogenic shock independently or in concert with or as a result of
another type of shock. Using multiple monitors and diagnostic tools can provide information that
will help guide appropriate treatment, diagnosis and support as the resuscitation process unfolds.
Volume Replacement
Fluid resuscitation remains the first intervention recommended to support all shock
patients particularly in hemorrhagic shock. At first suspicion, treatment should be initiated
before a definitive diagnosis is determined (Rosenthal Saner & Chawla , 2008) Currently, there
is ongoing debate in regards to best method of fluid resuscitation. Points of consideration in
resuscitation strategy include choosing the type of fluid to deliver, large versus small volumes,
early versus late fluid administration and the delivery of red blood cells and blood products.
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Crystalloid solution remains the mainstay choice for fluid resuscitation and there are
different compositions to choose from. Commonly used crystalloids are Lactated Ringers (LR)
and 0.9% normal saline. Normal saline, considered an unbalanced salt solution, delivers sodium
content that exceeds plasma sodium concentration thereby placing the patient at risk of
developing hyperchloremic metabolic acidosis when delivered in high volumes. Because of this,
balanced salt solutions are recommended over all for repletion of electrolytes that are essential to
cellular physiological function of body processes. (Smorenberg, Ince & Groeneveld, 2013).
Balanced solutions, such as LR, have a buffering effect and reduce the chance of developing an
acidotic state related to the fluid administration and is preferred over normal saline in
resuscitation (Smorenberg, Ince & Groeneveld, 2013). Evidence also suggests that LR spares
stress on renal function and decreases occurrence of acute kidney injury compared to normal
saline and colloid administration. Balanced solutions will not replete specific deficits of
potassium, calcium and magnesium; these are best repleted with direct intravenous
supplementation to foster adequate cardiac and metabolic functioning (Smorenberg, Ince &
Groeneveld, 2013).
Over the years, use of colloids in fluid resuscitation has gone in and out of favor. Up to
30% of delivered crystalloid volume delivered is lost to interstitial tissue and potentially supports
the benefit of colloid based fluid administration to draw fluid into the vascular space
(Rasmussen, Johansson, Hojskov, Kridina, Kistorp, Thind, Nielsen, Ruhnau Pedersen, and
Secher, 2014). Frequent debate continues in regard to whether concomitant delivery of colloids
with crystalloid solution is beneficial to the hemorrhaging patient. Studies reveal that although
delivery of colloids increases intravascular oncotic pressure they have been shown to alter the
coagulation competence in bleeding patients (Rasmussen, Johansson, Hojskov, Kridina, Kistorp,

SHOCK IN THE SURGICAL PATIENT

8

Thind, Nielsen, Ruhnau Pedersen, and Secher, 2014). A small randomized controlled trial that
compared delivery of lactated ringers with the colloid solution hydroxyethyl starch (HES) to
replete intraoperative blood loss revealed marked alterations of coagulation in the group
receiving HES. Also, reduced development and strength of blood clots, a significant decrease in
fibrinogen and platelet count and increased blood loss volume was observed in the patients
receiving HES when compare to the group receiving LR (Rasmussen, Johansson, Hojskov,
Kridina, Kistorp, Thind, Nielsen, Ruhnau Pedersen, and Secher, 2014). This artificial colloid was
shown to reduce clot strength by reducing polymerization of fibrinogen, producing a clot that
contains less fibrin and has less elasticity (Rasmussen, Johansson, Hojskov, Kridina, Kistorp,
Thind, Nielsen, Ruhnau Pedersen, and Secher, 2014). Furthermore, findings also showed that
the HES group required far less volume of crystalloid solution requirement and roughly twice as
much volume of PRBC’s to meet determined hemodynamic parameters for the study. The group
receiving LR required far less PRBC transfusion but required two thirds more crystalloid volume
administration to maintain the parameters and resulted in fluid excess when compared to the
HES group (Rasmussen, Johansson, Hojskov, Kridina, Kistorp, Thind, Nielsen, Ruhnau
Pedersen, and Secher, 2014). A larger randomized trial involving 2,857 subjects by Orbegozo et
al. reveals a slightly decreased mortality rate associated with colloid based resuscitation when
compared to crystalloid based resuscitation but concurs that a clear advantage to colloid based
initial fluid resuscitation is still controversial (2014). A ratio of 1:3 to 1:4 colloids to crystalloid
is suggested to reap the benefits of both types of fluid output (Smorenberg, Ince & Groeneveld,
2013).
Large volume resuscitation compared to smaller volume resuscitation and early compared
to delayed fluid administration during hemorrhage have been studied to determine best practice
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in treating volume depletion in hemorrhage (Kwan, Bunn, Chinnock & Roberts, 2014). Findings
revealed small differences in mortality in each group comparison; earlier and larger fluid
administration was associated with a slightly higher mortality rate but the authors did assert that
the quality of the studies under review were inconclusive to determine solid guidelines for fluid
resuscitation strategy. Unique factors such as the nature and location of the hemorrhage were
mentioned as variables that could potentially require differences in timing and volume of fluids
for the best outcomes. It was purported that larger, well concealed randomized controlled studies
need to be conducted to derive solid evidence based data for the hemorrhaging patient in regard
to volume and timing of fluid administration (Kwan, Bunn, Chinnock & Roberts, 2014).
Fluid resuscitation, although necessary, does come with complications. Excessive fluid
replacement can cause a cyclic phenomenon for the patient experiencing shock. While fluid
resuscitation does increase cardiac filling and raise blood pressure it also triggers the body to halt
compensatory vasoconstriction when increased intravascular volume is detected. This leads to an
increase in the rate of bleeding while adding strain to developing blood clots as vasodilation
occurs. More bleeding results and hypotension and reflexive vasoconstriction once again ensues
(Dutton, 2007).
Currently goal directed fluid therapy that maximizes the individuals’ needs during
resuscitation is favored over liberal crystalloid administration to initially treat shock. Low
volume resuscitation and hypotensive resuscitation are terms used for this concept and include a
target systolic blood pressure of at least 70 mmHg and a mean arterial pressure (MAP) of at least
50 mmHg compared to standard parameter goals of systolic pressure of 80-100mmHg and a
MAP of 65 mmHg (Bouglé, Harrois & Duranteau, 2013). According to Smorenberg, Ince &
Groeneveld, restricting fluid administration to less than 7 ml/kg/hr is associated with less
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complications compared to a more liberally infused volume common to resuscitation strategies in
the past (2013). Generally the lower volume concept includes rapid delivery of one to two liters
of fluid (Mandel & Palevsky, 2015) then titrating fluid administration to a target heart rate, blood
pressure and MAP to avoid hemodilution and dilution of clotting factors while helping to
maximize the body’s compensatory mechanisms in response to shock (Bouglé, Harrois &
Duranteau, 2013). However, consideration of the individual patient needs and underlying
pathophysiology always needs to be considered when planning fluid resuscitation.
Blood Cells, Plasma and Platelets
In hemorrhagic shock fluid replacement alone is not enough to support the patient.
Intravascular volume can be replaced with fluids but red blood cells, clotting factors and platelets
administration are also necessary to achieve homeostasis. Hematocrit levels between 25-30%
should be maintained by early administration of packed red blood cells as needed. It is generally
accepted that one unit of packed red blood cells will increase the hemoglobin level by 1 gm/dL
and a 3% increase in hematocrit concentration, although 2% increase in hematocrit is probably
more accurate due to studies basing the increase on 500 ml volumes of PRBC infusions and the
average volume of one unit of packed red blood cells is approximately 300-350 ml. (Elzik,
Dirschl & Dahners, 2006).
Past recommendations identifying parameters that indicate when to transfuse packed red
blood cells followed the “10/30” rule; transfusion was initiated to keep the hemoglobin above
10gm/dL and the hematocrit at 30% (Carson & Kleinman, 2015). These parameters were
rethought as transfusion related complications became better understood. Studies began to reveal
that there was no significant increase in morbidity and mortality when adhering to the 10/30 rule
but did show increased incidences of transfusion related complications such as transfusion
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related acute lung injury (TRALI) and exposure to blood born pathogens from donated blood
(Carson & Kleinman, 2015). Current literature purports that a hemoglobin level of 7-8 gm/dL is
acceptable and does not require transfusion. Hemoglobin of 6 gm/dL or less is considered a
critical value and indicates immediate need for replacement of red blood cells for oxygen
delivery capability (Carson & Kleinman, 2015).
An exception to this threshold-based transfusion method is appreciated in the setting of
acute blood loss. In hemorrhagic shock where compensatory mechanisms to maintain adequate
blood pressure and tissue perfusion are failing and the patient is presenting with symptoms;
tachycardia, myocardial ischemia with no response to fluid resuscitation, threshold-based
transfusion method is ineffective and immediate transfusion is required (Carson & Kleinman,
2015).
Fresh frozen plasma (FFP) plasma and platelet administration along with red blood cells
have been shown to increase survival in the setting of hemorrhage (Rasmussen, Johansson,
Hojskov, Kridina, Kistorp, Thind, et al., 2014). FFP administration should be initiated along with
delivery of PRBC’s to maintain adequate circulating levels of clotting factors. The amount and
timing in regard to PRBC to FFP administration ratio has been under study in the literature and
recent findings are controversial (Bouglé, Harrois & Duranteau, 2013). A PRBC/FFP ratio 1:3 or
1:4 has been acceptable but studies assessing alterations in coagulation have instigated the more
current recommendations suggesting a 1:2 ratio (Bouglé, Harrois & Duranteau, 2013). Current
military studies focused on acute traumatic blood loss reveal that a 1:1:1 ratio, PRBC’s to FFP to
platelets, have shown improved outcomes in emergency resuscitation efforts but Bouglé, Harrois
& Duranteau report that studies reveal early death from hemorrhagic shock is associated with
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higher PRBC to FFP ratios (2013). Platelet administration should be initiated to maintain a
platelet count of greater than 50,000.
Diagnostic Tools
Evaluation of laboratory tests can assist in the identification and presence of shock and
help determine the level of organ failure involved. Integral laboratory tests that are extremely
useful in diagnosing and treating shock include serum lactate, complete blood count, basic and
comprehensive metabolic panel, and coagulation profile and arterial blood gas analysis.

An increased serum lactate level can offer indirect information on how well body tissues
are being perfused. Serum lactate level is a direct reflection of anaerobic metabolism occurring
in the body system and reflects low oxygen delivering capacity and a hypo-perfused state.
Lactate levels rise when anaerobic respiration at a cellular level is being utilized as a
compensatory attempt to oxygenate tissues to maintain organ function. Normal compensatory
mechanisms can maintain blood pressure initially while hypoxia at the tissue level has already
begun; this is otherwise known as “cryptic shock” (Gaieski, 2015). Monitoring lactate level is a
valuable tool allowing for early intervention before symptoms and the shock cascade progress.
Lactate levels are considered normal at 2mmol/L; levels greater than 4.0 mmol/L are associated
with a 30-40% increase in mortality (Rosenthal Saner &Chawla, 2008).
Hematological studies are useful in the detection, diagnosis and treatment of hemorrhagic
shock and allow the practitioner to assess hemoglobin, hematocrit, platelet count, white blood
cell count and coagulation. Trending hemoglobin and hematocrit levels provides information
during resuscitation efforts. Having knowledge of expected increase in these blood values when
transfusions are being administered can help the provider discern the possibility of continuing
occult blood loss.
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Coagulation studies such prothrombin time, international normalized ratio, activated
partial thromboplastin time, fibrin and fibrinogen levels and d-dimer can provide information
about the coagulopathic state of the patient in shock. Coagulopathy is associated with longer
hospital stays, longer time on mechanical ventilation and higher incidence of multi-organ failure
and mortality. The ‘vicious triad’ of acidosis, hypothermia and hemodilution that occurs in shock
initiates coagulopathy. (Cohen and Kutcher, 2015). Acidosis has been determined to cause
clotting dysfunction in experimental models at a pH less than 7.2 and physical exposure in the
operating room, fluid administration, and the effects of general anesthesia all contribute to
hypothermia and can worsen coagulopathy. The effect of hypothermia on clotting includes
platelet dysfunction and impaired enzymatic function (Cohen and Kutcher, 2015). Providers
should undertake specific measures to correct hypothermia including controlling physical
exposure, administration of warmed fluids, and passive rewarming with blankets and forced-air
devices. In hemorrhage, rapid identification and control of bleeding is vital to preserve normal
temperature. Continuous temperature monitoring is essential to ensure that mild hypothermia
does not worsen (Cohen and Kutcher, 2015). Alterations in clotting that are induced by large
volumes of fluid or unbalanced blood component administration during the management of
shock are known as resuscitation-associated coagulopathy (Cohen and Kutcher, 2015).
Historically, resuscitation placed focus on treatment of hypotension and acidosis with aggressive
crystalloid resuscitation followed by packed red blood cells. Studies revealed that resuscitation
with crystalloid, colloid, and packed red blood cells leads to dilution of plasma clotting proteins
and a current recommendation for those receiving larger volumes of blood products and fluids
should receive packed red blood cells, fresh frozen plasma and platelets to avoid deleterious
effects associated with coagulopathy (Cohen and Kutcher, 2015).
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Obtaining basic and comprehensive metabolic panels offer a wide variety of information
in the shock state. These studies are valuable when evaluating the extent of end organ damage
related to shock and can help to stage shock in the patient. Testing of basic electrolytes such as
potassium, calcium, chloride, carbon dioxide, magnesium and phosphorus provides a snapshot of
fluid and electrolyte balance of the patient. In the later stages of shock hyponatremia,
hyperkalemia and hypercalcemia can present as a result of the altered membrane function,
cellular edema and cell death (Tintinalli, 2010). Excessive fluid administration alters serum
sodium levels and monitoring and correction is necessary. Receiving blood transfusions in large
volumes can instigate elevated levels of potassium and calcium associated with preservatives and
the aging process of red blood cells in banked blood. Blood urea nitrogen and creatinine levels
can offer a reflection of kidney function and/or extent of kidney failure. A comprehensive panel
that includes assessment of liver enzyme levels reflects hypoperfusion affecting hepatic function
and reflects end organ damage. Metabolic derangements are essential to support or correct
regardless of whether its etiology is related to the state of shock or occurring as a result of
interventions and treatments. The patient is at risk for life threatening consequences of altered
electrolyte balance such as cerebral edema, myocardial dysfunction, pulmonary edema and
interruption of essential cellular metabolic functions.
Arterial blood gas analysis is an integral laboratory tool, revealing the degree of
metabolic acidosis that presents in shock states; acidosis increases in severity as shock
progresses. Blood gas analysis guides the anesthetist to determine need for intubation and
mechanical ventilation and mitigate and treat progressing acidosis with appropriate ventilator
settings. Obtainment of cardiac enzymes is a fast way to determine if cardiac ischemia and tissue
damage is has occurred in the setting of hypoperfusion.
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Vasopressor Support
In the setting of shock providing volume is crucial but control of systemic
vasoconstriction comes in close second. In situations where volume repletion with fluids and
blood products and homeostatic mechanism does not stabilize hemodynamic and circulatory
status vasopressors must be added to the supportive regime (Smorenberg, Ince & Groeneveld,
2013). Various vasoactive agents are available and can be tailored to the type of support needed
in the shock state.
Epinephrine is the mainstay emergency vasopressor. It is the first line catecholamine in
cardiopulmonary and anaphylactic shock and serves as second line therapy when used as a
vasopressor and positive inotropic agent. Effects are elicited on both alpha and beta-adrenergic
receptors and increased heart rate and enhanced cardiac output result.
Norepinephrine, an endogenous catecholamine with both alpha and beta adrenergic
properties, elicits a vasoconstrictive effect on both arterial and venous blood vessels resulting in
an increased mean arterial pressure, preload, and venous return. Meanwhile norepinephrine,
unlike epinephrine, helps to decrease heart rate and stroke volume in the shock patient.
Norepinephrine is indicated for use in distributive or vasodilatory shock (Rosenthal, Saner &
Chawla , 2008).
Phenylephrine is a selective alpha-adrenergic agonist and is useful in setting of adequate
cardiac output to increase mean arterial pressure, systemic vascular resistance and central venous
pressure. As seen in hemorrhage, phenylephrine can be utilized for hypotension associated with
vasodilation for restoration of blood pressure along with a decrease in cardiac output. (Rosenthal,
Saner & Chawla , 2008).
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Dopamine is both an alpha and beta adrenergic agonist that stimulates alpha, beta and
dopaminergic receptors and can be utilized in varying strengths to elicit desired responses. Low
dose therapy targets dopamine receptors and has had a history of being useful in enhancing renal
perfusion although current studies currently reveal that there is no appreciable increase in renal
perfusion related to low dose dopamine therapy. At moderate dosage dopamine has an inotropic
effect via stimulation of beta-receptors and high doses elicit alpha-1-receptor stimulation and
results in systemic vasoconstriction. Dopamine is helpful when bradycardia and vasodilatory
shock is present due to its inotropic effects in a low cardiac output state causing an increased
heart rate and vasoconstriction. Caution is warranted as dopamine in high doses increased
metabolic consumption of oxygen and can predispose the patient to cardiac arrhythmias and
myocardial infarction (Rosenthal, Saner & Chawla, 2008).
Dobutamine is a sympathomimietic agent that primarily stimulates beta 2 receptors
making it useful in the setting of cardiogenic shock with decreased cardiac output and increased
afterload due to its inotropic effect and ability to decrease systemic and pulmonary vascular
constriction. Dobutamine can be used in conjunction with norepinephrine to treat septic shock
with myocardial dysfunction present (Rosenthal, Saner & Chawla, 2008).
There are various pharmacological agents that are non-adrenergic in action and can be
used as adjuvant therapy for the shock patient. Calcium channel sensitizers are a class of
medication that are inotropic with a vasodilatory effect. They are indicated for use in severe low
output states and in heart failure. Levosimedan and Pimobendan are two agents in this class.
Prostaglandin III inhibitors, such as milrinone and amrinone, mobilize intracellular calcium
resulting in increased vasodilation and positive inotropic effect. These agents are known to
improve cardiac output in cardiogenic shock whether it be the primary shock state or a secondary
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state caused by hypovolemia or distributive shock. Calcium overload, ventricular arrhythmias
and cell death is a possibility with use of these agents (Rosenthal, Saner & Chawla, 2008).
Vasopressin, otherwise know as antidiuretic hormone (ADH), is a naturally occurring
stress hormone that acts on the kidneys in the collecting ducts to retain water and increases
peripheral vascular resistance thereby increasing blood pressure. The mechanism of action
involves the renin-angiotensin-aldosterone system to elicit its effects. Vasopressin delivery is
desirable especially in the setting where adrenergic agonists are failing to raise blood pressure.
Vasopressin is useful in the setting of hypovolemic shock and septic shock when naturally
occurring ADH is depleted. With sepsis, vasopressin can be combined with norepinephrine to
support hemodynamic status (Rosenthal, Saner & Chawla, 2008).
Continuum of Care

In shock early resuscitation attempts demand prioritizing interventions. Initiating
an advanced life support assessment should occur first and foremost when suspecting or
determining a shock state. Airway, oxygenation and circulation status are of vital importance.
Supplemental oxygen should be immediately initiated and the airway should be secured and
ventilation controlled if any compromise to maintaining effective spontaneous ventilation is
present or a decreasing level of consciousness is putting the patient at risk of failing to maintain
an effective airway.
Fluid resuscitation should be initiated at the first suspicion of shock. Crystalloid
resuscitation due to its ability to rapidly expand plasma volume and reverse hypotension related
to physiologic compensatory changes continues to be the first line treatment in an emergent
hemorrhage situation (Rasmussen, Johansson, Hojskov, Kridina, Kistorp, Thind, et al., 2014).
Fluid administration should be titrated to achieve hemodynamic goals and avoid excessive
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delivery. With the airway secure and initial volume bolus delivered the patient’s circulatory
status should be continually monitored and supported with crystalloid and/or colloid infusion and
addition of vasopressors, if required, to achieve hemodynamic goals. Concurrently, blood
samples should be obtained for laboratory testing; initially a serum lactate, hemoglobin and
hematocrit, BMP, platelet count and ABG should be drawn. Blood and FFP infusions should be
readied and administered if indicated by amount of PRBC’s delivered, obvious acute blood loss
or suspected by results of hematological studies. An arterial line and central line should be
placed if not already present to guide resuscitation efforts and offer arterial blood sampling.
Additional labs such as coagulation studies, ionized calcium, magnesium, and cardiac enzymes
can be drawn for further data. With suspicion for hemorrhagic shock, cessation of bleeding is the
number one priority to reverse the shock state and plans for return to the operating room for
exploration should be discussed with surgical team immediately. Treatment and support for
shock is a dynamic process requiring complex thinking and teamwork.
Clearly, there is a lot of controversy regarding the optimal resuscitation strategy to treat
shock and but the overriding goals remain the same: delivery of oxygen to tissues, avoiding
hypoxia, mitigating inflammation and avoiding organ dysfunction. There are many methods and
ways to achieve this safely as an anesthesia provider with expert understanding of the shock
continuum, prompt intervention, comprehensive monitoring and use of laboratory and diagnostic
tools to understand the needs of the patient and guide the resuscitation strategy. Development of
an algorithm of care to treat shock in the form of a cognitive visual aid can help ensure all
critical components of care are performed and help to reduce adverse consequences associated
with shock.
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